José Francisco Ramírez
Grupo de investigación
- Patología molecular inflamatoria y de tumores sólidos Accredited researcher (R3A)
Publicaciones destacadas
-
Quantitative Image Analysis of Fibrillar Collagens Reveals Novel Diagnostic and Prognostic Biomarkers and Histotype-Dependent Aberrant Mechanobiology in Lung Cancer
Autores:Referencia: Modern Pathology 2023. -
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
Autores:Referencia: Matrix Biology 2022. -
Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer
Autores:Referencia: International Journal Of Molecular Sciences 2022. -
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence
Autores:Referencia: Cancer Letters 2021. -
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
Autores:Referencia: Lung Cancer 2019. -
Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer
Autores:Referencia: Bmc Pulmonary Medicine 2019. -
Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery
Autores:Referencia: Cancers 2019. -
The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases
Autores:Referencia: Lung 2018. -
LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation
Autores:Referencia: Journal Of Thoracic Oncology 2016. -
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
Autores:Referencia: American Journal Of Respiratory And Critical Care Medicine 2016.